(GOG 0271) A Study of the Local and Systemic Effects of Intraperitoneal Chemotherapy in the Treatment of Previously-Untreated, Invasive Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma

PrintE-mail
Title (GOG 0271) A Study of the Local and Systemic Effects of Intraperitoneal Chemotherapy in the Treatment of Previously-Untreated, Invasive Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma
Contact NSHIP
Principal Investigator Adekunle Odunsi, MD PhD
Study Number 197311
PhasePilot
Summary The objectives are to determine the feasibility of obtaining peritoneal fluid, peritoneal washings, and peripheral blood in patients receiving intraperitoneal chemotherapy ovarian cancer at multiple institutions.
Eligibility
  • Patients must be enrolled on GOG 252. 
  • Patients must have signed an approved informed consent for specimen collection and participation in this translational research study. 
  • Patients must have an IP catheter placed prior to initiating platinum and taxane-based chemotherapy on GOG 252. 

Ineligible patients: 

  •  Patients who are not enrolled on GOG 252. 
  • Patients who have not had an IP catheter placed prior to initiating platinum and taxane-based IP chemotherapy on GOG 252. 
  • Patients who did not sign an approved informed consent for specimen collection and participation in this translational research study.
For more information about the clinical study go to Clinicaltrial.Gov